Showing results (91-100 of 218) with videos related to
Sort By:
Pageof 22
BMJ Open|December 4, 2021
Liothyronine for hypothyroidism: a candidate for disinvestment or in need of further research? A value of information analysisDyfrig A Hughes, Konstantinos Skiadas, Deborah Fitzsimmons, et al.BMC Research Notes|January 27, 2016
Multiple imputation of multiple multi-item scales when a full imputation model is infeasibleCatrin O Plumpton, Tim Morris, Dyfrig A Hughes, et al.BMJ Open|July 23, 2025
Exploring patient and professional perspectives on implementing pharmacogenomic testing in the UK primary care setting and estimating the cost-effectiveness: a mixed-methods study protocolSadaf Qureshi, Asam Latif, Dyfrig A Hughes, et al.BMJ Open|July 5, 2022
Adverse drug reactions, multimorbidity and polypharmacy: a prospective analysis of 1 month of medical admissionsRostam Osanlou, Lauren Walker, Dyfrig A Hughes, et al.British Journal of Clinical Pharmacology|September 24, 2021
Free-of-charge medicine schemes in the NHS: A local and regional drug and therapeutic committee's experienceSimon O'Callaghan, Robin E Ferner, Andrew Barron, et al.Drug Safety|March 23, 2011
Patient experiences of serious adverse drug reactions and their attitudes to medicines: a qualitative study of survivors of Stevens-Johnson syndrome and toxic epidermal necrolysis in the UKTehreem F Butt, Anthony R Cox, Helen Lewis, et al.Drug Safety|June 19, 2008
Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression: a systematic review and meta-analysisSara Ormerod, Sarah E McDowell, Jamie J Coleman, et al.BMJ Case Reports|June 21, 2011
Calciphylaxis associated with widespread pulmonary calcificationTarvinder Singh Dhanjal, Suresh B Babu, Gareth Beevers, et al.Drug Safety|January 22, 2022
Spontaneous Reporting to Regulatory Authorities of Suspected Adverse Drug Reactions to COVID-19 Vaccines Over Time: The Effect of PublicityRobin E Ferner, Richard J Stevens, Christopher Anton, et al.Pharmacoeconomics|March 10, 2018
New Medicines in Wales: The All Wales Medicines Strategy Group (AWMSG) Appraisal Process and OutcomesAlice Varnava, Robert Bracchi, Karen Samuels, et al.Pageof 22